SANDOSTATIN LAR DEPOT VS SALINE-CONTROL IN PEDIATRIC HYPOTHALAMIC OBESITY

善静定 LAR DEPOT 与盐水对照治疗小儿下丘脑肥胖症的比较

• 批准号: 7375436
• 负责人: PEDRO A VELASQUEZ-MIEYER
• 金额: $ 0.37万
• 依托单位: UNIVERSITY OF TENNESSEE HEALTH SCI CTR
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375436
• 关键词: SANDOSTATIN; LAR; DEPOT; VS; SALINE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Investigators plan to compare the body mass index of pediatric subjects with hypothalamic obesity who are treated with Sandostatin LAR Depot (40 mg) versus the administration of a saline-control in pediatric subjects; and secondly the investigators will evaluate the safety and tolerability of the Sandostatin LAR Depot treatment.

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。研究人员计划将使用Sandostatin LAR Depot(40毫克)治疗下丘脑肥胖症的儿童受试者的体重指数与接受生理盐水对照的儿童受试者的体重指数进行比较；其次，研究人员将评估Sandostatin LAR Depot治疗的安全性和耐受性。